In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Wearables

Last updated: September 15, 2025
Sponsor: University of California, Berkeley
Overall Status: Completed

Phase

N/A

Condition

Mental Disability

Dementia

Mild Cognitive Impairment

Treatment

In-Home Technology System

Limited In-Home Technology

Clinical Study ID

NCT05159557
1247267250000-4
2SB1AG059458-04A1
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment by integrating wearable devices (e.g., Apple Watches).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Caregivers are fluent/literate in English

  • Caregivers currently reside in the United States with spouse/family member who hasreceived a medical diagnosis of Alzheimer's disease, other dementia, or mildcognitive impairment

  • Caregivers primarily use a smartphone (e.g., iPhone, Android)

  • Caregivers have internet and WiFi service

Exclusion

Exclusion Criteria:

  • Caregivers providing care for individuals with known non-neurodegenerativeconditions affecting behavior and cognition

  • Caregivers providing care for individuals with longstanding Axis I psychiatricdisorder Caregivers providing care for individuals with metabolic disorder or majororgan dysfunction

  • Caregivers providing care for individuals with alcohol abuse or dependence (within 5years of dementia onset)

  • Caregivers providing care for individuals with head trauma with loss ofconsciousness greater than 30 minutes

  • Caregivers providing care for individuals with contraindications to MRI imaging

  • Caregivers providing care for individuals with large confluent white matter lesions

  • Caregivers providing care for individuals with significant systemic medical illness

  • Caregivers providing care for individuals who use a medication likely to affectcentral nervous system functions adversely

Study Design

Total Participants: 63
Treatment Group(s): 2
Primary Treatment: In-Home Technology System
Phase:
Study Start date:
August 22, 2022
Estimated Completion Date:
March 25, 2024

Study Description

This study aims to develop, refine, evaluate, and commercialize a hardware/software system designed to integrate in-home sensors and devices, Internet-of-Things technologies (i.e., devices that can be controlled and communicated with via the internet), and social networking to create a more safe and supportive home environment for caregivers and people who have Alzheimer's disease, other dementias, or mild cognitive impairment. The system monitors troublesome behaviors in people with dementia or mild cognitive impairment (e.g., wandering), and targets mechanisms (e.g., worry, social isolation) thought to link behavioral symptoms in people with dementia or mild cognitive impairment with adverse caregiver outcomes (declines in health and well-being). The system is designed to minimize demands on caregivers' limited time and energy and to provide a platform for data collection that can be used by researchers and care professionals.

Hypotheses:

  1. Caregivers in the active treatment condition will have better health and well-being (i.e., less caregiver depression, anxiety, loneliness, and burden) and greater user satisfaction compared to those in the control condition.

  2. The magnitude of the difference in health and well-being benefits for caregivers in the active treatment condition compared to those in the control condition will increase over time (reflecting additional bot learning and adjustment to changing caregiver needs).

  3. In the active treatment condition, greater utilization of features related to warnings (e.g., activating warnings, receiving warnings), social connection (e.g., adding Trusted Circle members), and information (e.g., accessing on-line resources through app) will be associated with greater decreases in depression and anxiety and greater increases in well-being.

Connect with a study center

  • University of California, Berkeley

    Berkeley, California 94720
    United States

    Site Not Available

  • University of California, Berkeley

    Berkeley 5327684, California 5332921 94720
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.